US Patent Issued to BioNTech, TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige on Aug. 18 for "Treatment using cytokine encoding RNA" (German Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,643, issued on Aug. 18, was assigned to BioNTech SE (Mainz, Germany) and TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige GmbH (Mainz, Germany).

"Treatment using cytokine encoding RNA" was invented by Ugur Sahin (Mainz, Germany), Lena Kranz (Mainz, Germany), Mathias Vormehr (Mainz, Germany), Mustafa Diken (Mainz, Germany), Sebastian Kreiter (Mainz, Germany) and Bodo Tillmann (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods and compositions for inducing an immune response in a subject comprising co-administering to the subject RNA en...